Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, Sunil Healthcare has informed that the 261st Meeting of the Board of Directors of the Company, is scheduled to be held on Wednesday, November 13, 2024 at the Registered office 38E/252A, Vijay Tower, 3rd Floor, Panchsheel Commercial Complex, Shahpur Jat, New Delhi-110049 (deemed venue), through video conferencing/Audio visual connection, to consider, approve and take on record the Un-audited Financial Results (both standalone and consolidated) for the 2nd quarter/1st half year ended on September 30, 2024 of the Financial Year 2024-25. Further, the Trading Window, under the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as already intimated on 28.09.2024 vide its letter dated 28.09.2024, shall remain close from October 01, 2024 till November 15, 2024.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Tata Chemicals | 1148.70 |
SRF | 2245.85 |
Pidilite Inds. | 3140.90 |
Aarti Inds | 511.25 |
Atul | 7853.60 |
View more.. |